CN101703737B - Chinese patent medicament for treating hepatic fibrosis - Google Patents
Chinese patent medicament for treating hepatic fibrosis Download PDFInfo
- Publication number
- CN101703737B CN101703737B CN2009102272245A CN200910227224A CN101703737B CN 101703737 B CN101703737 B CN 101703737B CN 2009102272245 A CN2009102272245 A CN 2009102272245A CN 200910227224 A CN200910227224 A CN 200910227224A CN 101703737 B CN101703737 B CN 101703737B
- Authority
- CN
- China
- Prior art keywords
- gram
- chinese patent
- grams
- hepatic fibrosis
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a Chinese patent medicament for treating hepatic fibrosis, and relates to a Chinese patent medicament, which aims to provide a Chinese patent medicament for treating hepatic fibrosis having good treatment effect. The invention adopts the technical scheme that the Chinese patent medicament comprises the following raw material medicaments by mass: 100 to 130g of turtle shell, 40 to 60g of pangolin scales, 60 to 80g of oyster shell, 30 to 50g of rhubarb, 50 to 70g of radix astragali, 40 to 60g of Chinese thorowax root, 40 to 60g of red paeony root, 60 to 80g of danshen root, 60 to 80g of zedoary, 40 to 60g of peach seed, 30 to 60g of barbary wolfberry fruit, 60 to 80g of longhairy antenoron herb and 40 to 60g of chicken's gizzard-membrane. Compared with the prior art, the Chinese patent medicament has the obvious advantage of good treatment effect, and is used for treating the hepatic fibrosis.
Description
Technical field:
The present invention relates to a kind of Chinese patent medicine, particularly a kind of Chinese patent medicine for the treatment of hepatic fibrosis.
Background technology:
Hepatopathy is a kind of commonly encountered diseases, frequently-occurring disease, hepatic fibrosis is the middle development link of of multiple hepatopathy, and hepatic fibrosis changes the back if can not get effective treatment, finally can develop into liver cirrhosis, cause patient's death, thereby the treatment hepatic fibrosis becomes the important step of liver disease.Yet Shang Weijian has the Western medicine at hepatic fibrosis, and the therapeutic effect of Chinese patent medicine is undesirable.
Summary of the invention:
The purpose of this invention is to provide the good a kind of Chinese patent medicine for the treatment of hepatic fibrosis of a kind of therapeutic effect.Technical scheme of the present invention is it is characterized in that: crude drug composition and the content thereof of making efficacy component are: Carapax Trionycis 100-130 restrains, Squama Manis 40-60 restrains, Concha Ostreae 60-80 restrains, Radix Et Rhizoma Rhei 30-50 restrains, Radix Astragali 50-70 restrains, Radix Bupleuri 40-60 restrains, Radix Paeoniae Rubra 40-60 restrains, Radix Salviae Miltiorrhizae 60-80 restrains, Rhizoma Curcumae 60-80 restrains, Semen Persicae 40-60 restrains, Fructus Lycii 30-60 restrains, Herba Lysimachiae 60-80 restrains and Endothelium Corneum Gigeriae Galli 40-60 restrains.The present invention has the good remarkable advantage of therapeutic effect compared with the prior art.
The specific embodiment:
The present invention has following embodiment:
Embodiment 1:
Carapax Trionycis 100 grams, Squama Manis (system) 40 grams, Concha Ostreae 60 grams, Radix Et Rhizoma Rhei 30 grams, the Radix Astragali 50 grams, Radix Bupleuri 40 grams, Radix Paeoniae Rubra 40 grams, Radix Salviae Miltiorrhizae 60 grams, Rhizoma Curcumae 60 grams, Semen Persicae 40 grams, Fructus Lycii 30 grams, Herba Lysimachiae 60 grams, Endothelium Corneum Gigeriae Galli 40 grams.
Preparation method is: with above-mentioned Carapax Trionycis; Squama Manis is ground into coarse powder and decocts with water, and for the second time amount of water is 10 times of dose, decocts after 3 hours; for the second time amount of water is 8 times of dose; decocted 3 hours, and added water for the third time, the water yield is 8 times of dose; decocted 1 hour; filter then, filtrate is standby, and above-mentioned all the other each medicines and decocting boil three times; after wherein Semen Persicae is pulverized; open the back at water and add, amount of water is 10 times of dose for the first time, decocts 1.5 hours; amount of water is 8 times of dose for the third time; decoct after 1 hour, filter twice filtrate and merge, place the concentrating under reduced pressure machine; concentrating under reduced pressure is that 1.32-1.35 (80 ℃) makes clear paste to relative density; with clear paste; cane sugar powder and dextrin mix, and make granule with granulator, 60 ℃ of oven dry back packing down; every bag 9 gram, above-mentioned clear paste: sucrose: English white=1: 3: 1.
Embodiment 2:
Carapax Trionycis 115 grams, Squama Manis (system) 50 grams, Concha Ostreae 70 grams, Radix Et Rhizoma Rhei 40 grams, the Radix Astragali 60 grams, Radix Bupleuri 50 grams, Radix Paeoniae Rubra 50 grams, Radix Salviae Miltiorrhizae 70 grams, Rhizoma Curcumae 70 grams, Semen Persicae 50 grams, Fructus Lycii 45 grams, Herba Lysimachiae 70 grams, Endothelium Corneum Gigeriae Galli 50 grams.
Preparation method is: with above-mentioned Carapax Trionycis; Squama Manis is ground into coarse powder and decocts with water, and for the second time amount of water is 10 times of dose, decocts after 3 hours; for the second time amount of water is 8 times of dose; decocted 3 hours, and added water for the third time, the water yield is 8 times of dose; decocted 1 hour; filter then, filtrate is standby, and above-mentioned all the other each medicines and decocting boil three times; after wherein Semen Persicae is pulverized; open the back at water and add, amount of water is 10 times of dose for the first time, decocts 1.5 hours; amount of water is 8 times of dose for the third time; decoct after 1 hour, filter twice filtrate and merge, place the concentrating under reduced pressure machine; concentrating under reduced pressure is that 1.32-1.35 (80 ℃) makes clear paste to relative density; with clear paste; cane sugar powder and dextrin mix, and make granule with granulator, 60 ℃ of oven dry back packing down; every bag 9 gram, above-mentioned clear paste: sucrose: English white=1: 3: 1.
Embodiment 3:
Carapax Trionycis 130 grams, Squama Manis (system) 60 grams, Concha Ostreae 80 grams, Radix Et Rhizoma Rhei 50 grams, the Radix Astragali 70 grams, Radix Bupleuri 60 grams, Radix Paeoniae Rubra 60 grams, Radix Salviae Miltiorrhizae 80 grams, Rhizoma Curcumae 80 grams, Semen Persicae 60 grams, Fructus Lycii 60 grams, Herba Lysimachiae 80 grams, Endothelium Corneum Gigeriae Galli 60 grams.
Preparation method is: with above-mentioned Carapax Trionycis; Squama Manis is ground into coarse powder and decocts with water, and for the second time amount of water is 10 times of dose, decocts after 3 hours; for the second time amount of water is 8 times of dose; decocted 3 hours, and added water for the third time, the water yield is 8 times of dose; decocted 1 hour; filter then, filtrate is standby, and above-mentioned all the other each medicines and decocting boil three times; after wherein Semen Persicae is pulverized; open the back at water and add, amount of water is 10 times of dose for the first time, decocts 1.5 hours; amount of water is 8 times of dose for the third time; decoct after 1 hour, filter twice filtrate and merge, place the concentrating under reduced pressure machine; concentrating under reduced pressure is that 1.32-1.35 (80 ℃) makes clear paste to relative density; with clear paste; cane sugar powder and dextrin mix, and make granule with granulator, 60 ℃ of oven dry back packing down; every bag 9 gram, above-mentioned clear paste: sucrose: English white=1: 3: 1.
The pharmacological action of prescription of the present invention has the function of blood circulation promoting and blood stasis dispelling, softening the hard mass removing food stagnancy, invigorating spleen to remove dampness.
Instructions of taking: 9 gram/bags, each three times, one time one bag, warm boiled water, half an hour clothes after meal, be a course of treatment half a year, the taboo diabetes patient.This medicine is taken proof through routine patients up to a hundred for many years, chronic hepatitis and liver cirrhosis are obtained curative effect preferably, not only effectively improve liver function, reduce the effect of hepatic fibrosis index, when treatment reached for 6 each months, the spleen that dwindles enlargement and the arteries and veins internal diameter of broadening are also had tangible effect.Clinical effective rate reaches more than 90%, and cure rate reaches more than 70%.
Concrete case is as follows:
Opening little bad male 41 years old identification card number is: 410782196803133058, Lao Meng village, Wu villages and small towns, Huixian City, weak, poor appetite, abdominal distention appear, go to a doctor in my institute, be diagnosed as early stage liver cirrhosis on inspection, oral front three the liver benefiting granule, clinical symptom disappearance after half a year, the check liver function is normal fully, liver B ultrasonic inner diameter of portal vein is obviously dwindled.
56 years old identification card number of Qin Juhua woman is: 470611195310190040, Kang Jia village, collection township, Hebi City Hebi, weak, poor appetite, abdominal distention, two lower limbs edema appear, go to a doctor in my institute, be diagnosed as cirrhotic ascites on inspection, hospitalization ascites is left hospital after disappearing, and oral front three liver granule is 1 year after leaving hospital, do not occur ascites in 1 year, the check liver function is clearly better, liver B ultrasonic inner diameter of portal vein is obviously dwindled.
40 years old identification card number of the just outstanding man of Lu is: 4105261969042253778, Pei Zhuan village, village, Xunxian town, weak, poor appetite appears, clinical diagnosis is a chronic hepatitis, proving degree of hepatic fibrosis through needle biopsy of liver is IV phase (early stage liver cirrhosis), through the particulate treatment of front three the liver benefiting, clinical symptom disappearance after 3 months, after 1 year once more needle biopsy of liver proof degree of hepatic fibrosis obviously to alleviate degree be the II phase.
Claims (1)
1. Chinese patent medicine for the treatment of hepatic fibrosis is characterized in that: the crude drug of making efficacy component forms and content is: Carapax Trionycis 100-130 gram, Squama Manis 40-60 gram, Concha Ostreae 60-80 gram, Radix Et Rhizoma Rhei 30-50 gram, Radix Astragali 50-70 gram, Radix Bupleuri 40-60 gram, Radix Paeoniae Rubra 40-60 gram, Radix Salviae Miltiorrhizae 60-80 gram, Rhizoma Curcumae 60-80 gram, Semen Persicae 40-60 gram, Fructus Lycii 30-60 gram, Herba Lysimachiae 60-80 gram and Endothelium Corneum Gigeriae Galli 40-60 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102272245A CN101703737B (en) | 2009-11-20 | 2009-11-20 | Chinese patent medicament for treating hepatic fibrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102272245A CN101703737B (en) | 2009-11-20 | 2009-11-20 | Chinese patent medicament for treating hepatic fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101703737A CN101703737A (en) | 2010-05-12 |
| CN101703737B true CN101703737B (en) | 2011-02-09 |
Family
ID=42374037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102272245A Expired - Fee Related CN101703737B (en) | 2009-11-20 | 2009-11-20 | Chinese patent medicament for treating hepatic fibrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101703737B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013899B (en) * | 2014-06-25 | 2017-05-31 | 吉林大学 | A kind of Chinese medicine preparation and preparation method for treating liver fibrosis and cirrhosis |
| CN105148195A (en) * | 2015-09-26 | 2015-12-16 | 张文俊 | Chinese patent medicine for treating hepatitis B |
| CN106728688B (en) * | 2017-01-16 | 2020-06-02 | 周晓玲 | Chinese patent medicine for preventing hepatic fibrosis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1453014A (en) * | 2002-12-31 | 2003-11-05 | 张立中 | Chinese medicine prepn for preventing fibrillated liver and treating hepatocirrhosis |
-
2009
- 2009-11-20 CN CN2009102272245A patent/CN101703737B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1453014A (en) * | 2002-12-31 | 2003-11-05 | 张立中 | Chinese medicine prepn for preventing fibrillated liver and treating hepatocirrhosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101703737A (en) | 2010-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20020076446A1 (en) | Novel medicinal herbal composition for treating liver diseases and HIV | |
| CN103120742B (en) | Traditional Chinese medicine capsule for treating fatty liver and alcoholic liver and preparation method thereof | |
| EP1386614A1 (en) | Herbal pharmaceutical composition for treatment of hiv/aids patients | |
| CN101940716A (en) | Medicament for treating diabetic nephropathy | |
| CN101716298B (en) | Traditional Chinese medicine preparation for treating surgical intestinal adhesions | |
| CN100333757C (en) | Compound traditional Chinese medicinal prepn. for preventing and treating uterus abnormal bleeding disease, and its prepn. method | |
| CN103316305B (en) | Traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof | |
| CN101703737B (en) | Chinese patent medicament for treating hepatic fibrosis | |
| CN101361946A (en) | Traditional Chinese medicine combination for treating hepatitis B | |
| CN102198243B (en) | Oviduct dredging medicament for removing blood stasis and warming meridians | |
| CN103341133A (en) | Traditional Chinese medicine composition for treating fatty liver and preparation method thereof | |
| CN103223069A (en) | Traditional Chinese medicine composition for treating hepatitis | |
| CN102552512B (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN102552631A (en) | Chinese herbal preparation having protective effect on alcoholic hepatic injury | |
| CN1969940A (en) | Antivirus pharmaceutical composition | |
| CN102920862A (en) | Chinese medicinal composition for treating ascites due to cirrhosis | |
| CN107029173A (en) | A kind of pharmaceutical composition for treating primary carcinoma of liver | |
| CN102078571B (en) | Drug for treating early cirrhosis ascites | |
| CN102764411B (en) | Drug composite for curing jaundice and preparation method thereof | |
| CN1814250B (en) | Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN103212033B (en) | Drug composition for treating viral hepatitis | |
| CN102266533A (en) | Liver softening and regenerating granules and preparation method thereof | |
| CN101543566A (en) | Medicine composition for curing breast cancer and preparation method thereof | |
| CN101032613B (en) | Hepatic cyst-treating Chinese traditional medicine preparation and its preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110209 Termination date: 20121120 |